Bharat Biotech’s Covaxin effective against Delta variant studies by U.S. National Institute of Health (NIH)
India’s Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, effectively neutralizes both Alpha and Delta variants of Corona virus, the U.S.’ National Institute of Health has said. The National Institute of Health said results of two studies of blood serum from people who had received Covaxin suggest that the … Read more